THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading

THURSDAY, July 6, 2023 (HealthDay News) — Could swings in your blood fat levels increase your chances of being diagnosed with Alzheimer’s disease? Yes, suggests a new study that found fluctuating cholesterol levels among older adults may increase the risk for Alzheimer’s disease and other dementias. Those who had theContinue Reading

THURSDAY, July 6, 2023 (HealthDay News) — When frail patients go into cardiac arrest and need cardiopulmonary resuscitation (CPR) during surgery, they’re more likely to die than those who are stronger, a new study shows. Researchers from Brigham and Women’s Hospital in Boston studied the impact of frailty on survivalContinue Reading